Laura Brege, Director at ACADIA PHARMACEUTICALS INC (ACAD), sold 12,500 shares at $18.25 ($228K) on 2023-01-12, disclosed to the SEC on 2023-01-17.
Seasonal sale ($228k) by Director — this insider has traded ACAD in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| PCRX | BUY | 2024-08-19 | $13K | — | Filing → |
| ACAD | SELL | 2023-06-14 | $112K | — | Filing → |
| PCRX | SELL | 2023-06-07 | $23K | — | Filing → |